SPIN Unprocessed July 9, 2026 ai_technology finance
Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
View original on prnewswire.comOverview
LONDON, July 9, 2026 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX) announced today that it has entered into a definitive agreement for the immediate exercise of certain outstanding preferred investment options to purchase up to an aggregate of...
SpinGraph analysis pending — check back after processing.
Ask AI about this story
Opens with the SpinGraph .md URL and structured context — one click, prompt included.
More from PR Newswire Financial Services
View all →- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hub Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - HUBG
- Solaris Energy Infrastructure Set to Join S&P SmallCap 600
- ArcOne AI weitet den Einsatz von KI-Orchestrierung im Bankensektor aus
- Cognizant will die Zahl seiner „Frontier Certified Engineers" auf 5.000 und die seiner „Frontier Business Operators" auf 10.000 erhöhen
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Futu Holdings Ltd. of Class Action Lawsuit and Upcoming Deadlines - FUTU
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Solstice Advanced Materials, Inc. - SOLS
Markdown (.md) · JSON-LD schema (.json) · Machine-readable for AI & GEO